genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
Bioprocessing
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Coronavirus
Putting COVID-19 on the ‘Map’
News
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Coronavirus
COVID-19 Accurately Diagnosed by AI Model
Coronavirus
AstraZeneca Wins $1.2B from BARDA to Develop, Manufacture COVID-19 Vaccine
Animal Models
Gene for “Thinness” Identified that May Help to Resist Weight Gain
Cardiovascular Testing
Over 200 Genetic Factors Found Linked to Heart Arrhythmias
Insights
All
Trends for 2020
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
Bioprocessing
Digital Ecosystem Combines Process Control, Analytics, and Plant-Level Automation
Bioprocessing
Coronavirus Vaccine Race Approaching Quality Control Hurdle
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Coronavirus
AstraZeneca Wins $1.2B from BARDA to Develop, Manufacture COVID-19 Vaccine
Animal Models
Gene for “Thinness” Identified that May Help to Resist Weight Gain
Sponsored
Saving Science by Saving Mice
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Upcoming Webinars
DNA as Medicine: Encoding Cancer Therapeutic Antibodies
GENcast
Trends in Bioprocess 4.0 and their Impact on Biomanufacturing
Upcoming Webinars
Streamlining High-Throughput Impurity Analysis in Process Development
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Merck & Co
Merck & Co. Partnering with ISB to Study Targets for COVID-19 Therapeutics
Merck & Co
Merck & Co. Launches Up-to-$2.5B Cancer Collaboration with Taiho, Astex
Merck & Co
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen Cancer Pipelines
Merck & Co
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
Merck & Co
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co
Merck & Co. Partners with Themis on Measles Virus Vector-Based Vaccines
Merck & Co
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Merck & Co
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by...
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...
Merck & Co
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Merck & Co
Merck & Co. Plans Jobs Cuts, Shutdowns in Up-to-$1.2B Manufacturing Restructuring
Merck & Co
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Merck & Co
Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline
Merck & Co
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
